EDUCATIONAL OBJECTIVES

• Identify clinical features, including differential diagnoses for the various hematologic malignancies
• Implement strategies that incorporate state-of-the-art genomic analyses for hematologic malignancies
• Select patients with potential eligibility for immunotherapy
• List appropriate clinical trials for hematologic malignancies
• Identify the major patient management issues experienced by the interprofessional care team associated with hematologic malignancies
• Apply new strategies for incorporating therapies that target metabolism in blood cancers

TARGETED AUDIENCE

This activity has been designed for hematologists, medical and radiation oncologists, primary care physicians, pathologists, hematology/oncology fellows, oncology nurses, oncology social workers, and other healthcare professionals involved in the treatment of patients with blood cancer.

ACCREDITATION

In support of improving patient care, Penn Medicine is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

To find out more please visit the official event page.